home / stock / ptpi / ptpi news


PTPI News and Press, Petros Pharmaceuticals Inc. From 01/31/24

Stock Information

Company Name: Petros Pharmaceuticals Inc.
Stock Symbol: PTPI
Market: NASDAQ
Website: petrospharma.com

Menu

PTPI PTPI Quote PTPI Short PTPI News PTPI Articles PTPI Message Board
Get PTPI Alerts

News, Short Squeeze, Breakout and More Instantly...

PTPI - PLUG, PXLW and ASMB are among pre market gainers

2024-01-31 08:24:06 ET Guardion Health Sciences  ( GHSI ) +84% Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv Brand and Business to Doctor’s Best Inc Ensysce Biosciences  ( ENSC ) +33% Announces Positive End of Phase 2 M...

PTPI - Compugen, Iterum Therapeutics among healthcare movers

2024-01-30 10:00:05 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...

PTPI - CLS, CGEN and RCUS are among pre market gainers

2024-01-30 08:39:01 ET Iterum Therapeutics  ( ITRM ) +61% Announces Positive Topline Results from its Phase 3 REASSURE Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections. Kura Oncology  ( KURA ) +16% Reports Positive Preliminary Ziftomen...

PTPI - Petros Pharmaceuticals Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for STENDRA(R) (avanafil) Rx-to-OTC Switch

FDA requests meeting to review the Company's technology component and discuss further development and requirements NEW YORK, NY / ACCESSWIRE / January 24, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), a company focused on expanding consumer access to medication through over-the- count...

PTPI - NCAC, PTPI and CTSO among pre-market losers

2024-01-18 08:24:12 ET More on pre-market losers & stocks. Cytosorbents Corporation (CTSO) Q3 2023 Earnings Call Transcript Psyence's unit signs deal for up to $10M in funding via issuance of convertible notes Dawson James sees Cytosorbents' Cytosorb as approvabl...

PTPI - Evolus, Leap Therapeutics among healthcare movers

2024-01-17 10:00:18 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Health stocks to watch this earnings season as sector poised for resurgence Seeking Al...

PTPI - Petros Pharmaceuticals Demonstrates Positive Results Following Successful Completion of Initial Cohort of Phase 2 Equivalent Self-Selection Study for STENDRA (avanafil) Rx-to-OTC Switch

Over 78% of technology-enabled subjects correctly self-selected vs. 56% using drug facts label alone demonstrating continued progress toward STENDRA® working to become the first erectile dysfunction medication to successfully achieve OTC status NEW YORK, NY / ACCESSWIRE / January 17, 202...

PTPI - PAVM, CCLD and EDSA among mid-day movers

2023-12-12 12:30:31 ET Gainers: C4 Therapeutics ( CCCC ) +85% . Aditxt ( ADTX ) +71% . Icosavax ( ICVX ) +48% . IN8bio ( INAB ) +31% . Petros Pharmaceuticals ( PTPI ) +31% . Clean Earth Acquisitions Corp ( CLIN ) +26% ...

PTPI - Pharma Tuesday- 24/7 Market News Lunch Break 12 Dec 2023

2023-12-12 12:16:51 ET DENVER, Colo., Dec. 12, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Aditxt Inc (NASDAQ: ADTX), C4 Therapeutics Inc. (NASDAQ: CCCC), IN8bio Inc. (NASDAQ: INAB), Petros Pha...

PTPI - Rare Market Hours Announcement has this Listing Running Hard

2023-12-12 11:10:11 ET DENVER, Colo., Dec 12, 2023 ( www.247marketnews.com )- Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) reported, this morning, that it finished a Human Factors Study, to assess the technology component developed to facilitate patient’s access to its erectile dy...

Previous 10 Next 10